Revenue
406 thousand USD
2024 Q3 · USD
Exact inputs and evidence
- Revenue: 406000 USD Source
Market value is not computed: no recent price is available.
20 filing records in this dataset, filed from 2021-05-07 to 2024-11-12. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
406 thousand USD
2024 Q3 · USD
-4,450.99%
2024 Q3 · %
-19.8 million USD
2024 Q3 · USD
-19.8 million USD
2024 Q3 · USD
52620000 USD
2507171 shares
-96.58% · -70.8 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
2.67 million USD
2023-10-01 – 2024-09-30
-86.3 million USD
2023-10-01 – 2024-09-30
-80.4 million USD
2023-10-01 – 2024-09-30
425 thousand USD
2023-10-01 – 2024-09-30
-80.9 million USD
2023-10-01 – 2024-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-11-12.
Financial data available through: 2023-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 765,000
–
Current period
USD 2.91 million
–
2911000 − 765000 = 2146000 USD
765000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source2911000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 90.88 million
–
Current period
−USD 94.82 million
–
-94820000 − -90879000 = -3941000 USD
-90879000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-94820000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 87.09 million
–
Current period
−USD 73.65 million
–
-73647000 − -87094000 = 13447000 USD
-87094000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-73647000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 6.02 million
–
Current period
USD 970,000
–
970000 − 6022000 = -5052000 USD
6022000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source970000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | 0 | 61279000 Derived | -61279000 | 37492000 Derived | -98771000 | -56565000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 765000 | 94252000 Derived | -93487000 | -2608000 Derived | -90879000 | -93116000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 2911000 | 105712000 Derived | -102801000 | -7981000 Derived | -94820000 | -74617000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 765000 |
|
| 2023 | Revenue | 2911000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | 280.5% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | -12,220.5% |
|
| 2023 | Operating margin | -3,531.5% |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | -11,879.6% |
|
| 2023 | Net margin | -3,257.3% |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | -12,172% |
|
| 2023 | Free cash flow margin | -2,563.3% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -51701000 |
|
| 2022 | Operating cash flow | -87094000 |
|
| 2023 | Operating cash flow | -73647000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | -56565000 |
|
| 2022 | Free cash flow | -93116000 |
|
| 2023 | Free cash flow | -74617000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | 5.5% |
|
| 2022 | Liabilities / assets | 20.6% |
|
| 2023 | Liabilities / assets | 32.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | 51.57× |
|
| 2022 | Current assets / current liabilities | 19.01× |
|
| 2023 | Current assets / current liabilities | 10.51× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | −USD 27.95 million Exact valueExact value: -27945000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24.87 million Exact valueExact value: -24873000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.38 million Exact valueExact value: 1380000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26.25 million Calculation and evidence-24873000 − 1380000 USD Exact free cash flow: -26253000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 98.77 million Exact valueExact value: -98771000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 51.7 million Exact valueExact value: -51701000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.86 million Exact valueExact value: 4864000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 56.57 million Calculation and evidence-51701000 − 4864000 USD Exact free cash flow: -56565000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 90.88 million Exact valueExact value: -90879000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 87.09 million Exact valueExact value: -87094000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6.02 million Exact valueExact value: 6022000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 93.12 million Calculation and evidence-87094000 − 6022000 USD Exact free cash flow: -93116000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 94.82 million Exact valueExact value: -94820000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 73.65 million Exact valueExact value: -73647000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 970,000 Exact valueExact value: 970000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 74.62 million Calculation and evidence-73647000 − 970000 USD Exact free cash flow: -74617000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
20 filings · 1,144 latest values · 1,144 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001850906, 1850906, OMIC, edgar:1850906
Also known as SINGULAR GENOMICS SYSTEMS, INC., Singular Genomics Systems, Inc.